Document Detail


Multiple mechanisms limit the accumulation of unesterified cholesterol in the small intestine of mice deficient in both ACAT2 and ABCA1.
MedLine Citation:
PMID:  20724527     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Cholesterol homeostasis in the enterocyte is regulated by the interplay of multiple genes that ultimately determines the net amount of cholesterol reaching the circulation from the small intestine. The effect of deleting these genes, particularly acyl CoA:cholesterol acyl transferase 2 (ACAT2), on cholesterol absorption and fecal sterol excretion is well documented. We also know that the intestinal mRNA level for adenosine triphosphate-binding cassette transporter A1 (ABCA1) increases in Acat2(-/-) mice. However, none of these studies has specifically addressed how ACAT2 deficiency impacts the relative proportions of esterified and unesterified cholesterol (UC) in the enterocyte and whether the concurrent loss of ABCA1 might result in a marked buildup of UC. Therefore, the present studies measured the expression of numerous genes and related metabolic parameters in the intestine and liver of ACAT2-deficient mice fed diets containing either added cholesterol or ezetimibe, a selective sterol absorption inhibitor. Cholesterol feeding raised the concentration of UC in the small intestine, and this was accompanied by a significant reduction in the relative mRNA level for Niemann-Pick C1-like 1 (NPC1L1) and an increase in the mRNA level for both ABCA1 and ABCG5/8. All these changes were reversed by ezetimibe. When mice deficient in both ACAT2 and ABCA1 were fed a high-cholesterol diet, the increase in intestinal UC levels was no greater than it was in mice lacking only ACAT2. This resulted from a combination of compensatory mechanisms including diminished NPC1L1-mediated cholesterol uptake, increased cholesterol efflux via ABCG5/8, and possibly rapid cell turnover.
Authors:
Stephen D Turley; Mark A Valasek; Joyce J Repa; John M Dietschy
Related Documents :
11967727 - Anti-atherosclerotic efficacy of olmesartan.
12843267 - Presenilin redistribution associated with aberrant cholesterol transport enhances beta-...
20199377 - High-density lipoprotein: key molecule in cholesterol efflux and the prevention of athe...
16407187 - Cholesterol-regulated translocation of npc1l1 to the cell surface facilitates free chol...
3801927 - Long-term effects of lateral hypothalamic lesions on brown adipose tissue in rats.
21059027 - Effects of feed deprivation on standardbred horses fed a forage-only diet and a 50:50 f...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2010-08-19
Journal Detail:
Title:  American journal of physiology. Gastrointestinal and liver physiology     Volume:  299     ISSN:  1522-1547     ISO Abbreviation:  Am. J. Physiol. Gastrointest. Liver Physiol.     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-10-29     Completed Date:  2010-11-12     Revised Date:  2011-11-01    
Medline Journal Info:
Nlm Unique ID:  100901227     Medline TA:  Am J Physiol Gastrointest Liver Physiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  G1012-22     Citation Subset:  IM    
Affiliation:
Dept. of Internal Medicine, Univ. of Texas Southwestern Medical School, 5323 Harry Hines Blvd., Dallas, TX 75390-9151, USA. stephen.turley@utsouthwestern.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
ATP-Binding Cassette Transporters / genetics,  metabolism*
Analysis of Variance
Animals
Azetidines / pharmacology
Cholesterol / metabolism*
Diet
Esterification / drug effects
Homeostasis / drug effects
Intestinal Mucosa / drug effects,  metabolism*
Intestine, Small / drug effects,  metabolism*
Mice
Mice, Knockout
RNA, Messenger / genetics,  metabolism
Sterol O-Acyltransferase / genetics,  metabolism*
Grant Support
ID/Acronym/Agency:
DK078592/DK/NIDDK NIH HHS; GM07062/GM/NIGMS NIH HHS; HL09610/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/ATP binding cassette transporter 1; 0/ATP-Binding Cassette Transporters; 0/Azetidines; 0/RNA, Messenger; 163222-33-1/ezetimibe; 57-88-5/Cholesterol; EC 2.3.1.26/Sterol O-Acyltransferase; EC 2.3.1.26/sterol O-acyltransferase 2

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Incomplete reprogramming after fusion of human multipotent stromal cells and bronchial epithelial ce...
Next Document:  Effect of Aging on Gastric Mucosal Defense Mechanisms: ROS, apoptosis, angiogenesis and sensory neur...